Quantifying health impacts and economic costs of PM


Journal

International journal of public health
ISSN: 1661-8564
Titre abrégé: Int J Public Health
Pays: Switzerland
ID NLM: 101304551

Informations de publication

Date de publication:
May 2019
Historique:
received: 10 09 2018
accepted: 25 01 2019
revised: 20 01 2019
pubmed: 6 3 2019
medline: 23 7 2019
entrez: 6 3 2019
Statut: ppublish

Résumé

To estimate avoidable mortality, potential years of life lost and economic costs associated with particulate matter PM The health impact assessment method was followed. This method consists of: identification of health effects, selection of concentration-response functions, estimation of exposure, quantification of impacts quantification and economic assessment using the willingness to pay and human capital approaches. For 2013, we included data from 62 monitoring sites in ten cities, (113 municipalities) where 36,486,201 live. In 2015, we included 71 monitoring sites from fifteen cities (121 municipalities) and 40,479,629 inhabitants. It was observed that reduction in the annual PM Reducing PM

Identifiants

pubmed: 30834460
doi: 10.1007/s00038-019-01216-1
pii: 10.1007/s00038-019-01216-1
doi:

Substances chimiques

Air Pollutants 0
Particulate Matter 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

561-572

Subventions

Organisme : CONACYT
ID : 249441

Références

Lancet. 2000 Sep 2;356(9232):795-801
pubmed: 11022926
JAMA. 2002 Mar 6;287(9):1132-41
pubmed: 11879110
Lancet. 2002 Oct 19;360(9341):1233-42
pubmed: 12401268
Circulation. 2004 Jan 6;109(1):71-7
pubmed: 14676145
J Occup Environ Med. 2004 Apr;46(4):398-412
pubmed: 15076658
Environ Sci Technol. 2005 Apr 1;39(7):1954-61
pubmed: 15871223
Environ Res. 2006 Mar;100(3):431-40
pubmed: 16181621
Environ Health. 2009 Mar 03;8:7
pubmed: 19257892
Environ Int. 2011 Feb;37(2):342-8
pubmed: 21056471
Environ Health Perspect. 2012 Jul;120(7):965-70
pubmed: 22456598
Environ Health. 2013 May 28;12(1):43
pubmed: 23714370
Salud Publica Mex. 2014 Nov-Dec;56(6):579-91
pubmed: 25604409
Lancet. 2016 Oct 8;388(10053):1659-1724
pubmed: 27733284
Lancet. 2018 Nov 10;392(10159):1923-1994
pubmed: 30496105
BMJ. 1996 Jul 27;313(7051):183-4
pubmed: 8696181

Auteurs

Adrián Giovani Trejo-González (AG)

Environmental Health Department, Center for Population Health Research, National Institute of Public Health, Mexico City, Mexico.

Horacio Riojas-Rodriguez (H)

Environmental Health Department, Center for Population Health Research, National Institute of Public Health, Universidad No. 655 Colonia Santa María Ahuacatitlán, C.P. 62100, Cuernavaca, Morelos, Mexico. hriojas@insp.mx.

José Luis Texcalac-Sangrador (JL)

Environmental Health Department, Center for Population Health Research, National Institute of Public Health, Tlalpan, Mexico City, Mexico.

Carlos Manuel Guerrero-López (CM)

Environmental Health Department, Center for Population Health Research, National Institute of Public Health, Universidad No. 655 Colonia Santa María Ahuacatitlán, C.P. 62100, Cuernavaca, Morelos, Mexico.

Karla Cervantes-Martínez (K)

Environmental Health Department, Center for Population Health Research, National Institute of Public Health, Tlalpan, Mexico City, Mexico.

Magali Hurtado-Díaz (M)

Environmental Health Department, Center for Population Health Research, National Institute of Public Health, Universidad No. 655 Colonia Santa María Ahuacatitlán, C.P. 62100, Cuernavaca, Morelos, Mexico.

Luz Angélica de la Sierra-de la Vega (LA)

Environmental Health Department, Center for Population Health Research, National Institute of Public Health, Universidad No. 655 Colonia Santa María Ahuacatitlán, C.P. 62100, Cuernavaca, Morelos, Mexico.

Pamela Estrellita Zuñiga-Bello (PE)

School of Tourism, Autonomous University of Morelos State (UAEM), Av. Universidad 1001, Col. Chamilpa, 62210, Cuernavaca, Mexico, Morelos, Mexico.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH